| HOSPIRA, Inc. (NY:HSP) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $49.42 | 52 Week High | $52.79 | ||
| Open | $49.13 | 52 Week Low | $21.21 | ||
| Day High | $49.65 | P/E | 19.42 | ||
| Day Low | $49.08 | EPS | $2.55 | ||
| Volume | 222,442 | ||||
| More HSP Info: Chart SEC Filings Profile Historical Options | |||||
...more
Christopher B. Begley - Chairman, CEO
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| CE | 4 | SFSF | 4 |
| BIDU | 4 | AGN | 3 |
| DSPG | 3 | EVVV | 3 |
| BAX | 3 | MCO | 3 |
| SWN | 3 | STJ | 3 |
| TLAB | 3 | HOT | 3 |
No comments are currently available.
on Dec 15, 2009
at 01:02 PM Complete or Partial Acquisition Did Hospira acquire all of Orchid or just its injectable manufacturing facilities and antimicrobial franchises? Doesn't Orchid have a proprietary compound development unit and was it part of the deal?
Article: Hospira (HSP) to Acquire Orchid Chemical's Generic Injectable Finished-Dosage Form Business for Approx. $400M
on Oct 28, 2009
at 05:29 PM ANDREW OLIVER SATCHELL GOOD
Article: Trading Radar for 10/27: Visa (V), Baidu.com (BIDU), WYNN Resorts (WYNN), RF Micro (RFMD), BP (BP) Report